AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
May 18 2023
Analysis
The CDC will no longer track COVID-19 cases. Is that a mistake?
In a move that marks a turning point in the COVID-19 public health crisis, the Centers for Disease Control and Prevention's (CDC) Covid Data Tracker, a once-revered source of information regarding the number of COVID-19 cases in the United States, has made its penultimate update. The final one will occur on June 1, 2023, to reconcile historical data; after that, the CDC will no longer track
SalonNov 17 2021
Analysis
Fact-checking 5 viral Covid-19 vaccine falsehoods
Since vaccines were first authorized for use nearly a year ago, swarms of anti-vaxxers have pushed a variety of unfounded claims suggesting the vaccine is unsafe and urging people not to receive one.
Even with 58.5% percent of Americans fully vaccinated and mandatory vaccines for federal employees and contractors set to go into effect, anti-vaccine misinformation is still commonplace.
CNN Fact CheckMay 07 2021
News
The Statistical Secrets of Covid-19 Vaccines
THE CREATION AND distribution of vaccines against Covid-19 has been as close as science gets to a miracle—the culmination of centuries of infectious disease research, a mastery of viral genomics, the creation of a whole new kind of vaccinology, and speed in the face of crisis. So it’s weird that even as the global pandemic worsens (infection and death rates have gone vertical in India and
WiredMay 05 2023
News
WHO Declares Covid-19 Pandemic Emergency Over
The World Health Organization declared an end to the Covid-19 emergency, signaling that one of the most deadly and economically devastating pandemics in modern history is receding as the disease that caused it becomes a routine illness.
Covid-19 is here to stay, but the pandemic has been in a downward trend for more than a year because people around the world have built up immunity to
Wall Street Journal (News)Mar 18 2024
News
Clinical and laboratory characteristics of patients hospitalized with severe COVID-19 in New Orleans, August 2020 to September 2021 - Scientific Reports
In this study we have characterized the demographic, clinical and laboratory aspects of COVID-19 among a population that experienced a disproportionate impact of the pandemic. Among the patients admitted with COVID-19, approximately 1 in 2 received supplemental oxygen, 1 in 3 received high-flow oxygen, and 1 in 10 died during their hospitalization. Our analysis is consistent with other reports
Nature.comSep 26 2022
News
Q&A on Omicron-Updated COVID-19 Boosters
Earlier this month, the U.S. began administering the first COVID-19 booster vaccines that have been updated to better match the latest circulating coronavirus strains.
Many scientists expect the revised boosters will be more effective than their predecessors, but whether that’s the case and to what degree remains unknown.
The new vaccines, from mRNA vaccine makers Pfizer/BioNTech
FactCheck.orgDec 29 2020
News
Here’s the latest on COVID-19 vaccines
In the first data available since authorized immunizations began in the U.S. in December, the CDC reports 353 adverse events. Roughly 1.9 million doses have been served nationwide. Novavax has begun a phase three study of its COVID-19 vaccine in the U.S. and Mexico. The study will evaluate the vaccine’s safety and efficacy in up to 30,000 adults. The European Union has launched its mass
National GeographicDec 29 2020
Fact Check
A Guide to Moderna’s COVID-19 Vaccine
Moderna’s mRNA vaccine is the second COVID-19 vaccine authorized for use in the U.S. Here, we give a rundown of basic facts about the vaccine and an overview of how it works.
Quick Summary Vaccine name: mRNA-1273
Design type: mRNA
Dose number: 2 doses, 28 days apart
Efficacy: 94.1% efficacy in preventing symptomatic COVID-19 in adults two weeks or more after receipt
FactCheck.orgDec 23 2020
Fact Check
A Guide to Moderna’s COVID-19 Vaccine
Moderna’s mRNA vaccine is the second COVID-19 vaccine authorized for use in the U.S. Here, we give a rundown of basic facts about the vaccine and an overview of how it works.
Quick Summary - Vaccine name: mRNA-1273
Design type: mRNA; Dose number: 2 doses, 28 days apart
Efficacy: 94.1% efficacy in preventing symptomatic COVID-19 in adults two weeks or more after receipt of
FactCheck.orgDec 14 2020
Analysis
The Covid-19 vaccine’s 2 big challenges
The US has authorized a coronavirus vaccine. That doesn’t guarantee a quick end to the pandemic.
America has, finally, authorized a Covid-19 vaccine for the general public. Priority groups — health care workers and people in nursing homes — are now starting to get a vaccine. And if things go right, most of the country could be vaccinated by the end of next summer.
But that’s the
Vox